Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-05

FDA Approved: BOSENTAN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Sun Pharmaceutical Industries' supplemental application for bosentan, enabling the generic bosentan product to proceed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)